DANAHER CORPORATION's ticker is DHR and the CUSIP is 235851102. A total of 802 filers reported holding DANAHER CORPORATION in Q3 2013. The put-call ratio across all filers is 0.51 and the average weighting 0.6%.
About DANAHER CORPORATION
Danaher Corporation is a global science and technology company that designs, manufactures, and markets innovative products and services to professional, medical, industrial, and commercial customers. The company operates through four segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions.
Danaher's Life Sciences segment provides a range of research tools to scientists around the world, including mass spectrometry, chromatography, and automation systems. The Diagnostics segment offers a broad range of diagnostic products, including clinical chemistry, immunoassay, microbiology, and molecular diagnostic systems. The Dental segment provides a range of dental equipment and consumables, including imaging systems, dental instruments, and consumables. The Environmental & Applied Solutions segment offers a range of products and services to help customers protect the environment and improve productivity.
Danaher has a strong track record of growth and innovation, driven by its focus on continuous improvement and customer satisfaction. The company has a culture of operational excellence, which has enabled it to consistently deliver high-quality products and services to its customers. Danaher's management team is highly experienced and has a proven track record of creating value for shareholders.
In conclusion, Danaher Corporation is a well-established and innovative company that is well-positioned to continue delivering strong growth and value to its shareholders. With its focus on operational excellence and customer satisfaction, Danaher is a company that investors should keep an eye on.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $349,723,745 | +9.1% | 1,409,608 | +5.5% | 0.51% | +5.1% |
Q2 2023 | $320,543,520 | -6.2% | 1,335,598 | -1.5% | 0.49% | -10.2% |
Q1 2023 | $341,783,127 | -4.9% | 1,356,067 | +0.2% | 0.54% | -15.1% |
Q4 2022 | $359,316,837 | +0.8% | 1,353,767 | -1.9% | 0.64% | +5.3% |
Q3 2022 | $356,416,000 | +6.5% | 1,379,907 | +4.5% | 0.60% | +8.8% |
Q2 2022 | $334,648,000 | -12.1% | 1,320,007 | +1.7% | 0.56% | +8.8% |
Q1 2022 | $380,583,000 | -34.2% | 1,297,458 | -26.2% | 0.51% | -16.9% |
Q4 2021 | $578,560,000 | +6.7% | 1,758,489 | -1.2% | 0.62% | +0.2% |
Q3 2021 | $542,002,000 | +88.2% | 1,780,325 | +65.9% | 0.61% | +78.5% |
Q2 2021 | $287,991,000 | +33.2% | 1,073,151 | +11.7% | 0.34% | +22.0% |
Q1 2021 | $216,267,000 | +76.1% | 960,845 | +73.8% | 0.28% | +53.3% |
Q4 2020 | $122,784,000 | +0.3% | 552,731 | -2.7% | 0.18% | -20.3% |
Q3 2020 | $122,374,000 | +37.7% | 568,309 | +13.1% | 0.23% | +21.6% |
Q2 2020 | $88,887,000 | +18.2% | 502,668 | -7.5% | 0.19% | -4.0% |
Q1 2020 | $75,197,000 | -37.9% | 543,293 | -31.2% | 0.20% | -16.8% |
Q4 2019 | $121,166,000 | +17.0% | 789,456 | +10.1% | 0.24% | +11.7% |
Q3 2019 | $103,532,000 | +36.2% | 716,831 | +34.7% | 0.21% | +38.3% |
Q2 2019 | $76,035,000 | +68.1% | 532,009 | +55.3% | 0.15% | +77.0% |
Q1 2019 | $45,227,000 | -36.2% | 342,576 | -50.2% | 0.09% | -44.9% |
Q4 2018 | $70,897,000 | -19.2% | 687,573 | -14.9% | 0.16% | -2.5% |
Q3 2018 | $87,761,000 | +4.5% | 807,667 | -5.1% | 0.16% | +0.6% |
Q2 2018 | $83,964,000 | +90.8% | 850,867 | +89.3% | 0.16% | +117.6% |
Q1 2018 | $44,003,000 | -27.6% | 449,421 | -31.4% | 0.07% | -35.1% |
Q4 2017 | $60,766,000 | -15.7% | 654,667 | -22.1% | 0.11% | -22.4% |
Q3 2017 | $72,078,000 | +30.1% | 840,267 | +28.0% | 0.15% | +15.7% |
Q2 2017 | $55,399,000 | +28.0% | 656,467 | +29.7% | 0.13% | +12.4% |
Q1 2017 | $43,284,000 | +228.5% | 506,067 | +199.0% | 0.11% | +135.4% |
Q4 2016 | $13,176,000 | -51.4% | 169,267 | -51.0% | 0.05% | -51.5% |
Q3 2016 | $27,105,000 | +2200.9% | 345,767 | +2863.6% | 0.10% | +1880.0% |
Q2 2016 | $1,178,000 | -30.2% | 11,667 | -34.4% | 0.01% | -28.6% |
Q1 2016 | $1,687,000 | -38.4% | 17,787 | -39.7% | 0.01% | -46.2% |
Q4 2015 | $2,739,000 | -11.5% | 29,487 | -18.8% | 0.01% | 0.0% |
Q3 2015 | $3,094,000 | -75.9% | 36,310 | -75.8% | 0.01% | -69.0% |
Q2 2015 | $12,864,000 | +26.0% | 150,300 | +24.9% | 0.04% | +10.5% |
Q1 2015 | $10,213,000 | -47.9% | 120,300 | -47.4% | 0.04% | -39.7% |
Q4 2014 | $19,619,000 | +348.3% | 228,900 | +297.4% | 0.06% | +320.0% |
Q3 2014 | $4,376,000 | +43660.0% | 57,600 | +43208.3% | 0.02% | – |
Q2 2014 | $10,000 | -88.2% | 133 | -88.3% | 0.00% | – |
Q1 2014 | $85,000 | -99.3% | 1,133 | -99.4% | 0.00% | -100.0% |
Q3 2013 | $12,989,000 | -7.8% | 187,381 | -15.8% | 0.06% | -17.1% |
Q2 2013 | $14,083,000 | +1.9% | 222,481 | 0.0% | 0.07% | -2.8% |
Q1 2013 | $13,827,000 | – | 222,481 | – | 0.07% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
ARTHUR M. COHEN & ASSOCIATES, LLC | 232,593 | $60,115,000 | 16.52% |
Defender Capital, LLC. | 139,231 | $35,988,000 | 14.10% |
Third Point | 2,700,000 | $697,383,000 | 12.60% |
Riverstone Advisors, LLC | 62,416 | $16,121,000 | 10.38% |
Eos Focused Equity Management, L.P. | 32,304 | $8,344,000 | 9.87% |
Alphinity Investment Management Pty Ltd | 1,185,235 | $306,134,000 | 9.81% |
AGF Investments America Inc. | 88,205 | $22,782,000 | 8.41% |
Front Street Capital Management, Inc. | 117,802 | $30,427,000 | 7.70% |
CORTLAND ASSOCIATES INC/MO | 164,142 | $42,396,000 | 7.55% |
THAMES CAPITAL MANAGEMENT LLC | 57,156 | $14,763,000 | 7.33% |